These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 21064091

  • 1. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Heymans J, Benoy IH, Poppe W, Depuydt CE.
    Int J Cancer; 2011 Aug 15; 129(4):903-9. PubMed ID: 21064091
    [Abstract] [Full Text] [Related]

  • 2. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.
    BJOG; 2006 Nov 15; 113(11):1303-7. PubMed ID: 16978225
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
    Kudoh A, Sato S, Itamochi H, Komatsu H, Nonaka M, Sato S, Chikumi J, Shimada M, Oishi T, Kigawa J, Harada T.
    Int J Clin Oncol; 2016 Jun 15; 21(3):580-7. PubMed ID: 26614089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
    Zielinski GD, Rozendaal L, Voorhorst FJ, Berkhof J, Snijders PJ, Risse EJ, Runsink AP, de Schipper FA, Meijer CJ.
    Gynecol Oncol; 2003 Oct 15; 91(1):67-73. PubMed ID: 14529664
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ, Song HL, Wang JL, He Q, Qiu ZC, Li F.
    Asian Pac J Cancer Prev; 2015 Oct 15; 16(10):4297-302. PubMed ID: 26028089
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG, Penna C, Marchionni M, Bussani C, Pieralli A, Andersson KL, Fambrini M.
    Eur J Gynaecol Oncol; 2008 Oct 15; 29(4):378-82. PubMed ID: 18714574
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J.
    Gynecol Oncol; 2006 Nov 15; 103(2):631-6. PubMed ID: 16780934
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F, Pulinthanathu R, Elgert P, Cangiarella J, Simsir A.
    Diagn Cytopathol; 2015 May 15; 43(5):381-7. PubMed ID: 25546355
    [Abstract] [Full Text] [Related]

  • 20. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
    Nagai Y, Maehama T, Asato T, Kanazawa K.
    Gynecol Oncol; 2000 Nov 15; 79(2):294-9. PubMed ID: 11063660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.